Physician profile
Amy Bodrog
NPI 1003234709
$210.48
in general payments reported to CMS, 2019-2025
8 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.23 · 2024: $84.04 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163 · Education: $30.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.60 |
| Education | $30.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmaessentia USA Corporation | $35.94 | 2024-2025 | Besremi |
| Merck Sharp & Dohme LLC | $31.05 | 2020-2025 | Keytruda, Keytruda Qlex |
| Pfizer INC. | $30.65 | 2025 | |
| Janssen Biotech, INC. | $28.57 | 2025 | Rybrevant |
| Jazz Pharmaceuticals INC. | $23.55 | 2024 | |
| Celgene Corporation | $22.08 | 2024 | Reblozyl |
| Genentech USA, INC. | $21.01 | 2024 | Phesgo, Kadcyla, Perjeta |
| E.R. Squibb & Sons, L.L.C. | $17.63 | 2025 | Opdivo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bodrog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.